Archives
-
Hypoxia-Pathway Induction Restricts Measles and Nipah
2026-08-27
A 2025 study shows that pharmacological inhibition of prolyl-hydroxylase domain enzymes activates the HIF-dependent hypoxia response and restricts measles virus in vitro and ex vivo. The same strategy also reduced Nipah virus infection in hamster cerebellum and lung cultures, supporting host-directed antiviral investigation while leaving clinical efficacy unresolved.
-
Toremifene Versus Tamoxifen in Advanced Breast Cancer
2026-08-27
This Cochrane review evaluated whether toremifene provides clinically meaningful advantages over tamoxifen for advanced breast cancer. Its synthesis found no clear difference across tumor response, progression, survival, or selected adverse-event outcomes, while emphasizing limitations in trial quality and evidence certainty.
-
Bicinchoninic Acid Assay Kit K4102
2026-08-26
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit K4102 measures low-concentration total protein samples, including many detergent-containing biochemical samples and cell lysates. It is intended for scientific research workflows such as sample normalization and should not be used for diagnostic, clinical, or medical testing.
-
Partial BACE Inhibition and Synaptic Transmission
2026-08-26
Satir et al. examined whether reducing amyloid-β production through partial BACE inhibition necessarily disrupts neuronal communication. Using primary cortical neurons and optical electrophysiology, the study found that moderate inhibition lowered Aβ secretion without measurable synaptic-transmission loss, whereas stronger inhibition produced functional impairment.
-
Primary Antibody Dilution Buffer for PCNSL Assays
2026-08-25
Translate single-cell findings on SLC2A5-driven fructose metabolism into reproducible tissue, cell, and RNA-localization assays. This workflow uses a BSA- and Triton X-100-containing antibody dilution buffer to improve practical control of background, antibody penetration, and signal consistency without overstating clinical relevance.
-
Pepstatin A in Aspartic Protease Workflows
2026-08-25
Pepstatin A provides a practical route to dissect pepsin, renin, HIV protease, and cathepsin D activity across purified-enzyme and cell-based models. This guide combines target-aware dosing, orthogonal validation, and troubleshooting with a metabolite-binding workflow adapted from a 2025 TET2 protocol.
-
BCA Protein Quantification Kit: Practical Guide
2026-08-24
The Bicinchoninic Acid Assay (BCA) Protein Quantification Kit, SKU K4102, supports sensitive total-protein measurement for dilute samples and many detergent-containing lysates. It is intended for scientific research workflows such as protein quantification for cell lysates and biochemical sample normalization, not diagnostic, clinical, or medical testing.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-08-24
The PKH26 Red Fluorescent Cell Linker Kit provides red fluorescent labeling of cell membrane lipid regions for longitudinal cell tracing and proliferation studies. It is intended for membrane-focused in vitro or in vivo workflows, not intracellular targets or non-membrane labeling.
-
Betaine Hydrochloride Research Workflow Guide
2026-08-23
Betaine hydrochloride, also called carboxymethyl(trimethyl)azanium chloride, is a high-purity, water-soluble research compound for controlled biochemical workflows. Its documented value is as a reagent or supplement component, not as a proven inhibitor of the inflammatory pathway studied with oridonin.
-
Perospirone: SM-9018 Free Base Research Guide
2026-08-22
Perospirone, also called SM-9018 free base, combines 5-HT2A and dopamine D2 receptor antagonism with 5-HT1A partial agonism. Recent evidence also identifies concentration-dependent inhibition of vascular Kv1.5-related currents, expanding its relevance from schizophrenia research to cardiovascular pharmacology studies.
-
NHE1, Olfr2, and Octanal in Macrophage Atherosclerosis
2026-08-22
This study identifies macrophage NHE1 as a downstream effector of octanal–Olfr2 signaling in atherosclerosis, linking calcium-dependent oxidative stress with NLRP3 inflammasome-associated inflammation. Its combined mouse and macrophage experiments provide a mechanistic framework for studying how lipid-peroxidation products influence plaque biology and for designing reproducible protein-detection assays.
-
Light-Inducible RNA Switches for Regulated Gene Therapy
2026-08-21
A 2026 Trends in Biotechnology study introduces a rationally designed light-inducible RNA-releasing protein (LIRP) that controls therapeutic protein production at the translation stage. By combining compact molecular design with AAV and cell-based delivery, the authors demonstrate light-regulated interventions in obesity and retinal neovascular disease models.
-
Chloroquine Diphosphate in Translational Cancer Research
2026-08-20
A mechanistic and strategic guide to using Chloroquine Diphosphate in autophagy assays, resistance models, and therapy-sensitization studies. The article connects lysosomal pathway modulation with findings from a cetuximab-resistance study while distinguishing evidence-backed conclusions from forward-looking hypotheses.
-
Sulfo-NHS-SS-Biotin: A Surface Assay Framework
2026-08-20
Sulfo-NHS-SS-Biotin provides reversible, water-compatible labeling of accessible protein amines. This guide explains how to use its disulfide chemistry to distinguish surface accessibility, enrichment, and true cell-surface organization without overinterpreting glycoRNA-associated findings.
-
Acifran and the Structural Future of Lipid Signaling
2026-08-19
A translational perspective on Acifran as a research probe for HCAR2/GPR109A and HCAR3/GPR109B, integrating cryo-EM evidence, assay strategy, receptor selectivity, and the practical requirements of lipid metabolism research.